Arkolith/Insider Trading/IDYA/Form 4

Throne Jason

Chief Legal OfficerIDEAYA Biosciences, Inc. (IDYA) · full profile →Form 4 · filed Dec 19, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$350K
Net Open-Market Flow
-$350K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2023Option exercise(M)10K$7.01$70K10K
Dec 15, 2023Sell(S)10K$35.04$350K0
Dec 15, 2023Option exercise(M)10K$13.34$133K10K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 18, 2023Option exercise(M)10K—$048K
Dec 15, 2023Option exercise(M)10K—$048K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001610717-23-000406) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML